Abstract:Summary Fructose is a monosaccharide,which is greatly sweeter than glucose and sucrose.In recent years,high fructose corn syrup has been widely used in beverages and food industry globally.However,the effect of fructose on human health has received much attention in current years.In this review,we mainly discussed the food source, absorption and metabolism of fructose,relationship between fructose and metabolic disorders,and recommendation intake of total sugar. Crystalline fructose is dried,ground,and highly pure.Fructose is found in most fruits and vegetables either as a monosaccharide or as a unit of sucrose.The ratio of fructose to glucose in most natural food is approximately 1∶1 . Fructose has the lowest glycemic index of all natural sugars.High-fructose corn syrup (HFCS) is a mixture of fructose and glucose,which is widely used in food industry,added into soft drinks and baked foods for its palatability and good taste.HFCS-42,HFCS-55 and HFCS-90 are three kinds of HFCS,and the number for each HFCS represents the percentage of fructose in the syrup.Free fructose is absorbed directly by intestine via facilitated transport involving GULT5 transport proteins.Unabsorbed fructose in intestine can cause abdominal symptoms such as diarrhea and abdominal pain.When fructose exists in a 1∶1 ratio with glucose,it can be absorbed mostly.Unlike glucose,fructose can be metabolized in liver,where it can be partially converted into glucose,and mostly metabolized to fatty acid, and the latter can be synthesized into triacylglycerol. Fructose is firstly metabolized into fructose 1-phosphate by fructose to kinase referred to as fructolysis. Unlike glycolysis, in fructolysis the triose glyceraldehyde lacks a phosphate group.Fructose 1-phosphate then is hydrolyzed by aldose B to form dihydroxy acetone phosphate and glyceraldehyde.DHAP can either be isomerized to glyceraldehyde 3-phosphate by triosephosphate isomersae or reduced to glycerol 3-phosphate by glycerol 3-phosphate dehydrogenase. The glyceraldehyde produced may also be converted to glyceraldehyde 3-phosphate by glyceraldehyde kinase or further converted to glycerol 3-phosphate by glycerol 3-phosphate dehydrogenase.The metabolism of fructose yields intermediates in the gluconeogenic pathway leading to glycogen synthesis as well as fatty acid and triglyceride synthesis.Triacylglycerol can be accumulated in liver to cause non-alcohol fatty liver and insulin resistance in liver. Triglycerides are incorporated into very-low-density lipoproteins,which are released from the liver destined toward peripheral tissues for storage in both fat and muscle cells.Then,triacylglycerol can also be transported to other organs and tissues to increase the risk of insulin resistance,obesity and cardiovascular disease. Based on the available evidence,WHO recommends a reduced intake of free sugars throughout the life to limit free sugars intake to less than 10% of total energy intake.WHO suggests a further reduction of the intake of free sugars to below 5% of total energy intake. In conclusion,there exits a relationship between fructose and non-alcohol fatty liver,obesity,cardiovascular disease and insulin resistance.Therefore,fructose should be applied in an appropriate way or it will exert a detrimental influence on health.It is reasonable to pay more attention on reducing fructose intake.

The small intestine shields the liver from fructose-induced steatosis

Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate

Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol‐Inducible Cytochrome P450‐2E1–Mediated Oxidative and Nitrative Stress

The propensity of fructose to induce metabolic dysfunction is dependent on the baseline diet, length of the dietary exposure, and sex of the mice.

Dietary fructose improves intestinal cell survival and nutrient absorption

Lipogenic Transcription Factor ChREBP Mediates Fructose-Induced Metabolic Adaptations to Prevent Hepatotoxicity

Targeting Intestinal Transporter Glut5 to Prevent the High Fructose-Induced Steatotic Liver Disease

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease

1849-P: Fructose Induces Hepatic Steatosis via ME1-Mediated Cytosolic Redox Status

Recent Progress on Fructose Metabolism-Chrebp, Fructolysis, and Polyol Pathway

High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions

"Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis

Absorption and Metabolism of Fructose and Its Relationship with Human Health

High-Fructose Diet Increases Inflammatory Cytokines and Alters Gut Microbiota Composition in Rats

Glycerate from intestinal fructose metabolism induces islet cell damage and glucose intolerance

The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease

Gut and liver metabolic responses to dietary fructose - are they reversible or persistent after switching to a healthy diet?

Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease

Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease

Fructose and hepatic insulin resistance

Fructose: a modulator of intestinal barrier function and hepatic health?